2023
Children's Oncology Group's 2023 blueprint for research: Rare tumors
Schultz K, Chintagumpala M, Piao J, Chen K, Gartrell R, Christison‐Lagay E, Berry J, Shah R, Laetsch T, Committee T. Children's Oncology Group's 2023 blueprint for research: Rare tumors. Pediatric Blood & Cancer 2023, 70: e30574. PMID: 37458616, PMCID: PMC10529839, DOI: 10.1002/pbc.30574.Peer-Reviewed Original ResearchMeSH KeywordsAdrenal Cortex NeoplasmsChildHumansMedical OncologyNasopharyngeal NeoplasmsRetinal NeoplasmsThyroid Neoplasms
2020
Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology–histopathology correlation in 7 patients
Darbinyan A, Morotti R, Cai G, Prasad ML, Christison‐Lagay E, Dinauer C, Adeniran AJ. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology–histopathology correlation in 7 patients. Cancer Cytopathology 2020, 128: 746-756. PMID: 32897650, DOI: 10.1002/cncy.22329.Peer-Reviewed Original ResearchConceptsDICER1 mutationsThyroid diseaseThyroid carcinomaScreening of patientsFine-needle aspiration samplesMonitoring of patientsDiagnostic cytologic featuresPapillary thyroid carcinomaGermline DICER1 mutationsThyroid fine-needle aspiration samplesFNA evaluationUndetermined significanceDifferent somatic variantsThyroid cancerScant colloidNeoplastic lesionsHistopathological analysisCytomorphologic featuresDICER1 syndromeModerate cellularityCytologic featuresFollicular carcinomaFollicular lesionsInconspicuous nucleoliFollicular neoplasm